The RadComp Study

The RadComp Study, short for Radiotherapy Comparative Effectiveness, is a nationwide clinical study comparing two FDA approved radiation therapies for the treatment of breast cancer, PHoton Therapy vs. PRoton Therapy.  With this study, we hope to better understand the best available technologies for breast cancer to help patients live a longer, healthier life.

Check out this short video for an overview of the study and how you can participate:

RadComp is “Patient Powered”

RadComp was designed with help from breast cancer patients. Patients told us they were most concerned about heart problems after therapy and how radiation might affect their quality of life. Thus, this study seeks to learn which type of radiation, PHoton Therapy vs. PRoton Therapy, will help breast cancer patients avoid heart problems, live longer, and have a better quality of life.

Testimonials

 (c)2017 l  ClinicalTrials.gov identifier: NCT02603341  l  Terms of Usel  Privacy Policy  l  SiteMap

The RadComp Study

The RadComp Study, short for Radiotherapy Comparative Effectiveness, is a nationwide clinical study comparing two FDA approved radiation therapies for the treatment of breast cancer, PHoton Therapy vs. PRoton Therapy.  With this study, we hope to better understand the best available technologies for breast cancer to help patients live a longer, healthier life.

Check out this short video for an overview of the study and how you can participate:

Display Menu

MENU

____

______

____